1,172 results on '"Alessandri, C."'
Search Results
2. POS1000 EXPRESSION OF GLYCOSYLATED DSRNA ON THE SURFACE OF MONOCYTES IN PATIENTS WITH SJOGREN SYNDROME
3. POS0361 PPARΒ/Δ TARGETING AS A POSSIBLE ROUTE TO CONTROL AUTOIMMUNE OVERREACTION: EVIDENCE FROM HUMAN IN VITRO STUDY
4. POS1131 EVOLUTIONARY TRAJECTORY OF UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE: IMPACT OF THE 2019 EULAR/ACR CLASSIFICATION CRITERIA FOR SYSTEMIC LUPUS ERYTHEMATOSUS
5. AB1011 COMPREHENSIVE DISEASE CONTROL IN SYSTEMIC LUPUS ERYTHEMATOSUS: WHEN REMISSION GOES HAND IN HAND WITH THE CONTROL OF CHRONIC DAMAGE
6. Retention rate of abatacept in rheumatoid arthritis patients in a real-life setting: results from a monocentric cohort.
7. The restoration site
8. Introduction
9. Wooden architraves
10. Monitoring
11. Immune checkpoint inhibitors and pre-existing antinuclear antibodies: the rheumatologist point of view
12. Impaired bone matrix glycoprotein pattern is associated with increased cardio-metabolic risk profile in patients with type 2 diabetes mellitus
13. Microparticles and autophagy: a new frontier in the understanding of atherosclerosis in rheumatoid arthritis
14. Native/citrullinated LL37-specific T-cells help autoantibody production in Systemic Lupus Erythematosus
15. Reduction of autophagy and increase in apoptosis correlates with a favorable clinical outcome in patients with rheumatoid arthritis treated with anti-TNF drugs
16. AB1343 PERSISTENCE OF SYMPTOMS AFTER SARS-CoV-2 INFECTION IN PATIENTS WITH INFLAMMATORY ARTHRITIS: A RETROSPECTIVE STUDY
17. POS1425 ANTIB2GLYCOPROTEIN I ANTIBODIES CAN INDUCE NETOSIS
18. POS0809 HARNESSING CELL ENERGY METABOLISM TO SUPPRESS SALIVARY GLAND INFLAMMATION IN SJÖGREN SYNDROME
19. AB0672 DETECTION OF MACROPHAGE MIGRATION INHIBITORY FACTOR IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS COMPLAINING PAINFUL DISTURBANCES: A SINGLE CENTER STUDY
20. POS1404 CAFFEINE IMPROVES SYSTEMIC LUPUS ERYTHEMATOSUS ENDOTHELIAL DYSFUNCTION BY PROMOTING ENDOTHELIAL PROGENITOR CELLS SURVIVAL
21. AB0429 EIGHT-MONTH FOLLOW-UP OF THE NON-MEDICAL SWITCH FROM ETANERCEPT BIO-ORIGINATOR TO GP-2015 OR SB4 ETANERCEPT BIOSIMILARS IN PATIENTS WITH CHRONIC INFLAMMATORY ARTHROPATHIES: A MONOCENTRIC OBSERVATIONAL STUDY
22. AB0126 EXPRESSION OF Β2 MICROGLOBULIN IN SALIVARY GLAND EPITHELIAL CELLS OF PATIENTS WITH SJOGREN SYNDROME
23. AB1320 COVID-19 OUTCOME IN AN ITALIAN RHEUMATOID ARTHRITIS COHORT
24. POS0337 CHARACTERIZATION OF CIRCULATING CHONDROPROGENITOR CELLS IN PATIENTS AFFECTED BY OSTEOARTHRITIS
25. AB0590 CROSS-SECTIONAL ASSESSMENT OF THE QUALITY OF LIFE IN SLE PATIENTS: ROLE OF DISEASE ACTIVITY, CHRONIC DAMAGE, FIBROMYALGIA SYNDROME AND MOOD DISORDERS
26. Anti-D4GDI antibodies activate platelets in vitro: a possible link with thrombocytopenia in primary antiphospholipid syndrome
27. S13.1 Developing systemic autoimmune diseases in healthy subjects persistently positive for antiphospholipid antibodies: long-term follow-up study
28. PO.7.148 Patients with systemic lupus erythematosus and their experience with vaccination against COVID-19: a descriptive and explanatory study
29. S03.1 Endothelial function in systemic lupus erythematosus patients: impact of caffeine consumption on endothelial progenitor cells survival
30. Patients with systemic lupus erythematosus and their experience with vaccination against COVID-19: a descriptive and explanatory study
31. Rigid inclusions in frictionless unilateral contact with the matrix: identification of maximum stiffness structures by means of BEM formulations and sensitivity analyses
32. AB0455 DRUGS, AUTOANTIBODIES AND GENES CONTRIBUTE TO THE DEVELOPMENT OF CHRONIC DAMAGE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
33. POS0741 REPORT FROM THE APS STUDY GROUP OF THE ITALIAN SOCIETY FOR RHEUMATOLOGY (SIR-APS) ON aPL NEGATIVIZATION
34. AB0118 PORPHYROMONAS GINGIVALIS AMOUNT IN THE TONGUE BIOFILM IS ASSOCIATED WITH EROSIVE ARTHRITIS IN SYSTEMIC LUPUS ERYTHEMATOSUS
35. POS0118 SMALL FIBER NEUROPATHY EVALUATION IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS: A SINGLE CENTER STUDY.
36. AB0499 LYMPHOID ORGANIZATION IN LUPUS NEPHRITIS: EVALUATING POSSIBLEAUTO ANTIGENS
37. AB0507 IMPACT OF CAFFEINE CONSUMPTION ON ENDOTHELIAL PROGENITOR CELLS SURVIVAL IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS
38. POS1058 BIOLOGICAL DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS IN PSORIATIC ARTHRITIS: PREDICTORS OF TREATMENT SURVIVAL IN A REAL-LIFE SETTING
39. POS0553 NEW BIOMARKERS IN RHEUMATOID ARTHRITIS: ROLE OF HOMOCYSTEINYLATED ANTI-ALPHA1 ANTITRYPSIN ANTIBODIES
40. POS1253 THE COURSE OF COVID-19 IN A COHORT OF SPONDYLOARTHRITIS PATIENTS: A CASE-CONTROL PROSPECTIVE STUDY
41. POS0428 PATHOGENETIC ROLE OF MICROPARTICLES IN RHEUMATOID ARTHRITIS
42. OP0236 JAK-STAT INHIBITION RESTORES EPITHELIAL CELLS’ HOMEOSTASIS IN PRIMARY SJOGREN’S SYNDROME
43. AB0119 ROLE OF COSTIMULATORY MOLECULES IN SYSTEMIC LUPUS ERYTHEMATOSUS: FOCUS ON CD137
44. POS0410 THE ROLE OF IL-6 IN ENDOTHELIAL DYSFUNCTION: RHEUMATOID ARTHRITIS AND COVID-19, TWO PATHOGENIC MODELS IN COMPARISON
45. POS0120 NEUROLOGICAL INVOLVEMENT IN A MONOCENTRIC COHORT OF PATIENTS WITH SERONEGATIVE ANTIPHOSPHOLIPID SYNDROME
46. AB0436 EFFECTIVENESS OF BELIMUMAB IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS: A REAL-LIFE ANALYSIS
47. Tofacitinib Decreases Autophagy of Fibroblast-Like Synoviocytes From Rheumatoid Arthritis Patients
48. Nativity Church narthex: A non-linear FEM procedure for the diagnosis of a structural damage
49. sCD163 in AOSD: a biomarker for macrophage activation related to hyperferritinemia
50. Clinical Delphi on aPLnegativization: report from the from the APS Study Group of the Italian Society for Rheumatology (SIR-APS)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.